Benzamidenafil
Names | |
---|---|
Preferred IUPAC name
N-[(3,4-Dimethoxyphenyl)methyl]-2-[(1-hydroxypropan-2-yl)amino]-5-nitrobenzamide | |
Other names
Xanthoanthrafil
| |
Identifiers | |
3D model (JSmol)
|
|
ChemSpider | |
MeSH | C442640 |
PubChem CID
|
|
UNII | |
| |
| |
Properties | |
C19H23N3O6 | |
Molar mass | 389.408 g·mol−1 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). | |
Infobox references | |
Benzamidenafil or xanthoanthrafil is a synthetic drug that acts as a PDE5 inhibitor. It has the same mechanism of action as pharmaceutical drugs used to treat erectile dysfunction, but it is not approved by any regulatory agency for such use.[1] It has been found as an undeclared adulterant in supposedly "natural" health supplements.[1][2] In 2009, the supplement manufacturer Hi-Tech Pharmaceuticals recalled its product Stamina-Rx because it was adulterated with benzamidenafil.[3]
References[]
- ^ a b Rica Lewis (Aug 16, 2013). "Stamina Rx Ingredients".
- ^ Zou, Peng; Hou, Peiling; Oh, Sharon Sze-Yin; Ge, Xiaowei; Bloodworth, Bosco Chen; Low, Min-Yong; Koh, Hwee-Ling (2008). "Identification of benzamidenafil, a new class of phosphodiesterase-5 inhibitor, as an adulterant in a dietary supplement". Journal of Pharmaceutical and Biomedical Analysis. 47 (2): 255–259. doi:10.1016/j.jpba.2008.01.004. PMID 18280079.
- ^ "FDA MedWatch – Stamina-Rx Dietary Supplement Products". Vanderbuilt University. Archived from the original on 2016-03-04. Retrieved 2014-09-14.
Categories:
- PDE5 inhibitors
- Benzamides
- Nitrobenzenes
- Anthranilic acids
- Catechol ethers
- Genito-urinary system drug stubs